Insulearn Feasibility With MDI - Trial NCT06411548
Access comprehensive clinical trial information for NCT06411548 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Virginia and is currently Not yet recruiting. The study focuses on Type 1 Diabetes Mellitus. Target enrollment is 10 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Virginia
Timeline & Enrollment
N/A
Jun 01, 2024
Dec 31, 2024
Primary Outcome
Low blood glucose index (LBGI)
Summary
This is a 24-hour, randomized, crossover, single-center trial where participants are
 randomized to either start with the InsuLearn intervention or the usual care (UC)
 intervention. In the InsuLearn intervention, insulin doses are optimized using data collected
 in a 4-weeks at home data collection period.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06411548
Device Trial